Showing results (1831-1840 of 3,794) with videos related to

Sort By:
Pageof 380
Oncoimmunology|June 25, 2026
Early neutrophil infiltration promotes TRIMELVax-induced antitumor immunity by linking local inflammation to tumor controlAmarilis Pérez-Baños, María Alejandra Gleisner, Andrés Tittarelli, et al.
Oncoimmunology|May 30, 2026
Umbilical cord blood natural killer cells improve anti-GD2 antibody efficacy in neuroblastoma: from mouse to humanMengjia Song, Yingxia Lan, Xiya Tan, et al.
Oncoimmunology|June 5, 2026
Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesisTara G Vrooman, Emily R Quarato, Gary Hannon, et al.
Oncoimmunology|May 17, 2017
Tumor-infiltrating neutrophils predict benefit from adjuvant chemotherapy in patients with muscle invasive bladder cancerLin Zhou, Le Xu, Lingli Chen, et al.
Oncoimmunology|August 6, 2026
Bi-directional support of T lymphoma and a lymphoma-associated monocyte population involving Notch signaling in miceSigrid Dubois, Yetzali Claudio-Medina, Jennifer L Marte, et al.
Oncoimmunology|July 30, 2026
Cancer associated fibroblast-T cell crosstalk promotes purinergic synthesis in non-small cell lung cancer (NSCLC)Lilian Koppensteiner, Charles Lochenie, Richard A O'Connor, et al.
Oncoimmunology|July 27, 2026
Characterization of persistent HPV-specific activated T cells in head and neck squamous cell carcinomaHiromasa Ishihara, Hirofumi Shibata, Daisuke Muraoka, et al.
Oncoimmunology|September 7, 2026
Broad targeting of HPV E proteins by intratumoral and systemic B cell responses in HPV+ head and neck cancerIlham Bahhar, Jacob P Conarty, Songzhu Zhao, et al.
Oncoimmunology|September 23, 2022
The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapyJiwei Huang, Ruopeng Su, Zeyu Chen, et al.
Oncoimmunology|October 17, 2022
AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastomaM I Strecker, K Wlotzka, F Strassheimer, et al.
Pageof 380